Petros Pharmaceuticals (PTPI) Short Interest Ratio & Short Volume $0.03 +0.00 (+5.19%) As of 06/20/2025 03:57 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Petros Pharmaceuticals Short Interest DataPetros Pharmaceuticals (PTPI) has a short interest of 456,800 shares, representing 4.60% of the float (the number of shares available for trading by the public). This marks a 91.85% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 3.14 million shares to cover all short positions.Current Short Interest456,800 sharesPrevious Short Interest238,100 sharesChange Vs. Previous Month+91.85%Dollar Volume Sold Short$15.12 thousandShort Interest Ratio0.0 Days to CoverLast Record DateMay 31, 2025Outstanding Shares31,160,000 sharesShort Percent of Float4.60%Today's Trading Volume274,634 sharesAverage Trading Volume3,143,842 sharesToday's Volume Vs. Average9% Short Selling Petros Pharmaceuticals? Sign up to receive the latest short interest report for Petros Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPTPI Short Interest Over TimePTPI Days to Cover Over TimePTPI Percentage of Float Shorted Over Time Petros Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2025456,800 shares $15.12 thousand +91.9%4.6%0 $0.03 5/15/2025238,100 shares $38.10 thousand -51.8%2.4%0 $0.16 4/30/2025493,800 shares $148.14 thousand -83.5%28.2%0.1 $0.30 4/15/20253,000,000 shares $138 thousand +102.7%30.2%0.1 $0.05 3/31/20251,480,000 shares $102.27 thousand +98.6%14.9%0 $0.07 3/15/2025745,300 shares $62.90 thousand +113.1%7.5%0.1 $0.08 2/28/2025349,800 shares $34.21 thousand -83.3%3.5%0.1 $0.10 2/15/20252,100,000 shares $615.30 thousand +187.3%21.1%0.4 $0.29 1/31/2025731,000 shares $204.46 thousand +15.7%N/A0.4 $0.28 1/15/2025631,800 shares $189.54 thousand -2.2%6.9%0.3 $0.30 Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/2024646,200 shares $254.54 thousand +139.6%7.1%0.3 $0.39 12/15/2024269,700 shares $88.95 thousand +48.9%3.0%0.2 $0.33 11/30/2024181,100 shares $49.69 thousand -9.7%2.0%0.9 $0.27 11/15/2024200,600 shares $51.96 thousand +0.7%2.2%1.1 $0.26 10/31/2024199,200 shares $73.70 thousand -27.2%2.2%1.2 $0.37 10/15/2024273,600 shares $83.39 thousand -7.2%3.1%1.4 $0.30 9/30/2024294,900 shares $105.28 thousand +25.4%3.4%1.3 $0.36 9/15/2024235,100 shares $85.65 thousand -20.6%2.7%0.8 $0.36 8/31/2024295,900 shares $98.45 thousand +13.5%3.5%0.8 $0.33 8/15/2024260,700 shares $86.97 thousand -40.0%3.1%0.6 $0.33 7/31/2024434,200 shares $176.29 thousand +69.9%7.1%1 $0.41 7/15/2024255,500 shares $116.00 thousand -28.5%4.2%0.6 $0.45 6/30/2024357,200 shares $163.42 thousand -23.7%5.8%1 $0.46 6/15/2024468,300 shares $194.58 thousand +202.3%7.7%1 $0.42 5/31/2024154,900 shares $95.14 thousand +82.9%2.5%0.3 $0.61 5/15/202484,700 shares $43.67 thousand -37.0%1.4%0.1 $0.52 4/30/2024134,500 shares $88.30 thousand +92.7%3.3%0.2 $0.66 4/15/202469,800 shares $54.66 thousand -52.3%1.7%0.1 $0.78 3/31/2024146,200 shares $216.38 thousand +65.4%3.6%0.1 $1.48 3/15/202488,400 shares $134.37 thousand -72.1%6.8%0.1 $1.52 2/29/2024317,200 shares $545.58 thousand +12.3%24.2%0.3 $1.72 2/15/2024282,400 shares $434.90 thousand +16.5%21.9%0.3 $1.54 1/31/2024242,400 shares $293.30 thousand +2,208.6%18.8%0.4 $1.21 1/15/202410,500 shares $13.81 thousand -74.8%0.8%0 $1.32 12/31/202341,700 shares $58.80 thousand -66.5%3.1%0.2 $1.41 12/15/2023124,300 shares $172.78 thousand +571.9%9.1%0.6 $1.39 11/30/202318,500 shares $29.60 thousand -28.3%1.4%0.2 $1.60 11/15/202325,800 shares $34.31 thousand -41.6%2.0%0.8 $1.33 10/31/202344,200 shares $63.21 thousand -27.9%3.5%1.3 $1.43 10/15/202361,300 shares $98.07 thousand +415.1%4.9%1.4 $1.60Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 9/30/202311,900 shares $20.59 thousand +213.2%0.9%0 $1.73 9/15/20233,800 shares $6.88 thousand -82.3%0.3%0 $1.81 8/31/202321,500 shares $54.83 thousand -62.7%1.7%0.1 $2.55 8/15/202357,700 shares $184.64 thousand -21.9%3.9%0.2 $3.20 7/31/202373,900 shares $296.34 thousand -79.4%5.0%0.2 $4.01 7/15/2023359,100 shares $1.14 million +1,330.7%24.3%0.5 $3.19 6/30/202325,100 shares $50.95 thousand -27.0%1.7%0 $2.03 6/15/202334,400 shares $89.78 thousand -10.7%2.3%0 $2.61 5/31/202338,500 shares $89.71 thousand -13.5%2.6%0 $2.33 5/15/202344,500 shares $186.90 thousand -88.5%3.0%0 $4.20 4/30/2023385,300 shares $1.66 million +1,029.9%27.3%0.2 $4.30 4/15/202334,100 shares $156.52 thousand -22.5%2.4%0 $4.59 3/31/202344,000 shares $61.38 thousand +14.9%3.1%3.1 $1.40 3/15/202338,300 shares $56.68 thousand +13.0%2.7%2.1 $1.48 2/28/202333,900 shares $71.19 thousand -6.6%2.4%1.6 $2.10 2/15/202336,300 shares $92.20 thousand +23.1%2.5%1.8 $2.54 1/31/202329,500 shares $76.70 thousand -24.4%2.1%1.5 $2.60 1/15/202339,000 shares $118.95 thousand +14.0%2.7%1.6 $3.05 12/30/202234,200 shares $79.69 thousand +14.8%2.4%1.4 $2.33 12/15/202229,800 shares $63.18 thousand +43.3%2.1%1.8 $2.12 11/30/202220,800 shares $8.55 thousand -92.2%1.4%1.5 $0.41 11/15/2022265,700 shares $130.19 thousand +78.6%N/A2.1 $0.49 10/31/2022148,800 shares $71.42 thousand +9.3%N/A1 $0.48 10/15/2022136,200 shares $58.53 thousand +77.3%N/A0.2 $0.43 9/30/202276,800 shares $39.17 thousand -36.1%N/A0.1 $0.51 9/15/2022120,200 shares $78.68 thousand -7.1%N/A0.1 $0.65 8/31/2022129,400 shares $84.82 thousand +45.4%N/A0.1 $0.66 8/15/202289,000 shares $71.63 thousand +420.5%N/A0.1 $0.80 7/31/202217,100 shares $13.57 thousand -22.3%N/A0 $0.79 7/15/202222,000 shares $18.10 thousand -56.2%N/A0.1 $0.82 6/30/202250,200 shares $42.16 thousand +46.8%N/A0 $0.84 6/15/202234,200 shares $26.74 thousand -81.0%N/A0 $0.78 5/31/2022179,500 shares $174.98 thousand +89.2%N/A0.1 $0.97 5/15/202294,900 shares $91.11 thousand -30.0%N/A0.1 $0.96 4/30/2022135,600 shares $153.23 thousand -26.0%N/A0.1 $1.13 4/15/2022183,300 shares $221.79 thousand -39.8%N/A0.1 $1.21 3/31/2022304,400 shares $474.86 thousand +15.1%N/A0.4 $1.56 3/15/2022264,500 shares $285.66 thousand -39.7%N/A0.1 $1.08 2/28/2022438,900 shares $605.68 thousand -38.5%N/A0.1 $1.38 2/15/2022714,000 shares $1.14 million -15.3%N/A0.1 $1.59 1/31/2022842,700 shares $1.46 million -54.9%N/A0.1 $1.73 1/15/20221,870,000 shares $4.90 million -19.7%N/A0.1 $2.62 12/31/20212,330,000 shares $7.76 million -22.9%28.1%0.1 $3.33 12/15/20213,020,000 shares $8.67 million +41.1%35.7%0.2 $2.87 11/30/20212,140,000 shares $6.12 million +459.6%55.9%0.2 $2.86 11/15/2021382,400 shares $833.63 thousand +359.6%8.9%0.1 $2.18 10/29/202183,200 shares $144.77 thousand -22.2%2.6%0 $1.74 10/15/2021106,900 shares $175.32 thousand +20.0%1.8%1.2 $1.64 9/30/202189,100 shares $178.20 thousand -22.9%1.5%1.6 $2.00 9/15/2021115,600 shares $239.29 thousand -20.8%1.9%2.1 $2.07Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 8/31/2021145,900 shares $328.28 thousand -16.1%2.4%1.8 $2.25 8/13/2021173,900 shares $525.18 thousand -9.1%2.8%1.7 $3.02 7/30/2021191,200 shares $581.25 thousand +19.3%3.1%0.9 $3.04 7/15/2021160,300 shares $488.92 thousand +18.3%2.6%0.8 $3.05 6/30/2021135,500 shares $424.12 thousand +21.1%2.2%0.7 $3.13 6/15/2021111,900 shares $349.13 thousand +105.0%1.8%0.5 $3.12 5/28/202154,600 shares $165.44 thousand -1.1%0.9%0.3 $3.03 5/14/202155,200 shares $162.84 thousand -18.9%0.9%0.3 $2.95 4/30/202168,100 shares $224.73 thousand +6.2%1.1%1.4 $3.30 4/15/202164,100 shares $201.92 thousand -19.0%1.0%0.8 $3.15 3/31/202179,100 shares $288.72 thousand +4.2%1.3%0.9 $3.65 3/15/202175,900 shares $256.54 thousand +20.5%1.2%0.5 $3.38 2/26/202163,000 shares $218.61 thousand -9.1%1.0%0.4 $3.47 2/12/202169,300 shares $293.83 thousand +234.8%1.1%0.4 $4.24 1/29/202120,700 shares $70.17 thousand +269.6%0.3%0.1 $3.39 1/15/20215,600 shares $24.14 thousand No ChangeN/A0 $4.31 PTPI Short Interest - Frequently Asked Questions What is Petros Pharmaceuticals' current short interest? Short interest is the volume of Petros Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 456,800 shares of PTPI short. 4.60% of Petros Pharmaceuticals' shares are currently sold short. Learn More on Petros Pharmaceuticals' current short interest. What is a good short interest percentage for Petros Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.60% of Petros Pharmaceuticals' floating shares are currently sold short. Is Petros Pharmaceuticals' short interest increasing or decreasing? Petros Pharmaceuticals saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 456,800 shares, an increase of 91.9% from the previous total of 238,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Petros Pharmaceuticals' short interest compare to its competitors? 4.60% of Petros Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Petros Pharmaceuticals: Purple Biotech Ltd (6.00%), 60 Degrees Pharmaceuticals, Inc. (1.30%), Enveric Biosciences, Inc. (14.23%), Spruce Biosciences, Inc. (0.08%), Oragenics, Inc. (11.98%), ZyVersa Therapeutics, Inc. (6.32%), Lixte Biotechnology Holdings, Inc. (0.49%), Aditxt, Inc. (0.74%), Palisade Bio, Inc. (4.79%), Affimed (4.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Petros Pharmaceuticals stock? Short selling PTPI is an investing strategy that aims to generate trading profit from Petros Pharmaceuticals as its price is falling. PTPI shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Petros Pharmaceuticals? A short squeeze for Petros Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PTPI, which in turn drives the price of the stock up even further. How often is Petros Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTPI, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Purple Biotech Short Squeeze 60 Degrees Pharmaceuticals Short Squeeze Enveric Biosciences Short Squeeze Spruce Biosciences Short Squeeze Oragenics Short Squeeze ZyVersa Therapeutics Short Squeeze Lixte Biotechnology Short Squeeze Aditxt Short Squeeze Palisade Bio Short Squeeze Affimed Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTPI) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PTPI Stock Free PTPI Stock Alerts